NASDAQ:GENE
Genetic Technologies Ltd Stock News
$2.36
+0.0400 (+1.72%)
At Close: May 01, 2024
20 Biopharma Stocks for Huge Upside Potential in 2020
12:05pm, Saturday, 11'th Jan 2020
Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
Mid-Day Market Update: Dow Surges Over 200 Points; Tufin Software Technologies Shares Plunge
12:00am, Thursday, 09'th Jan 2020Mid-Morning Market Update: Markets Mostly Flat; Walgreens Misses Q1 Expectations
12:00am, Wednesday, 08'th Jan 202020 Medical centers across 8 US states set to offer Breast Cancer Test
04:45pm, Tuesday, 07'th Jan 2020
Molecular diagnostics company Genetic Technologies Limited (ASX: GTG, NASDAQ: GENE) is pleased to advise that its third-generation breast cancer test (GeneType for Breast Cancer) is on track for comme
Read This Before Selling Genetic Technologies Limited (ASX:GTG) Shares
04:24am, Tuesday, 07'th Jan 2020
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
Genetic Technologies Files for Offering of 250M Unlisted Options
12:00am, Friday, 20'th Dec 2019Genetic Technologies to Hold Investor Webinar and Q&A Session on December 18
02:00pm, Tuesday, 17'th Dec 2019
MELBOURNE, Australia, Dec. 17, 2019 -- Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased to announce its interim-CEO, Dr. Jerzy Muchnicki, will share.
Genetype for Breast Cancer commissioned with sales to commence First Quarter 2020
12:00pm, Tuesday, 10'th Dec 2019
Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased to announce the full commissioning of its Australian Laboratory for the provisioning of its generation 3 breast cancer
Genetic Technologies Says Genetype For Breast Cancer Commissioned With Sales To Commence In Q1 2020
12:00am, Tuesday, 10'th Dec 2019Genetic Technologies Interview to Air on Bloomberg International on the RedChip Money Report
01:30pm, Friday, 15'th Nov 2019
MELBOURNE, Australia, Nov. 15, 2019 -- Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”), a diversified molecular diagnostics company, announced today an.
Genetic Technologies Interview to Air on Bloomberg International on the RedChip Money Report
12:00am, Friday, 15'th Nov 2019Genetic Technologies Provides Shareholder Update on Recent Achievements and Upcoming Milestones
12:00pm, Tuesday, 05'th Nov 2019
Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”), a diversified molecular diagnostics company, announced today an update to shareholders on recent achievements and upcoming milest
